Introduction
Ampicillin has good bactericidal activity; however, it can be degraded by -lactamases produced by various bacteria, including some of the methicillin-susceptible Staphylococcus aureus strains (MSSA) and most of the methicillinresistant strains (MRSA). Sulbactam is a -lactamase inhibitor and acts primarily by irreversible inactivation of -lactamases. The combination of ampicillin/sulbactam inhibits -lactamase activity and increases the spectrum of activity. According to previous reports and our in vitro experiments, the combination is effective, but is not powerful enough against MRSA, including strains producing -lactamase. 1, 2 Epigallocatechin gallate (EGCg; a main constituent of tea catechins) is synergic with -lactams against MRSA. [3] [4] [5] We hypothesized that ampicillin/sulbactam could be effective against MRSA if combined with EGCg.
Materials and methods

Antibiotics and EGCg
Nitrocefin was purchased from Oxoid (Basingstoke, UK). Oxacillin, methicillin, ampicillin, imipenem, cefmetazole and ampicillin/sulbactam were purchased from Sigma (St Louis, MO, USA). EGCg was extracted from green tea with a purity of 98% as confirmed by high-performance liquid chromatography analysis.
Bacterial strains and media
Twenty-eight clinical isolates of MRSA were obtained from Fujigaoka and Hatanodai Hospitals of Showa University. MSSA ATCC 25923 and -lactamase-producing MSSA 226 were used as controls. Cation-adjusted MuellerHinton broth and agar (Becton Dickinson, Cockeysville, MD, USA) were used for susceptibility tests. Heart infusion broth (HIB; Difco Laboratories, Detroit, MI, USA) was used for -lactamase tests.
-Lactamase tests and mecA gene detection
For -lactamase tests, an inoculum of 10 4 bacteria/well was incubated at 35°C overnight in 100 L HIB in the absence/ or presence of 0.5 mg/L methicillin, which was used to induce the -lactamase production. Fifty microlitres of nitrocefin 500 mg/L was then added to the cultures.
-Lactamase broke down the ring of nitrocefin resulting in a colour change from yellow to red. The colours were graded from no change (-) to dark red (3ϩ) at 5, 30, 60 and 120 min, respectively. All the strains were also identified by PCR analysis for mecA gene expression as reported previously. 6 
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Susceptibility tests
MICs were determined using the broth dilution and chequerboard methods at a final inoculum Ͼ5 ϫ 10 5 cfu/mL as reported previously. 6 Ampicillin/sulbactam combination was tested at a constant ratio of 2:1 as used in the clinically available formulation. MICs of ampicillin/sulbactam were presented as the concentrations of ampicillin. Synergy between ampicillin/sulbactam and EGCg was evaluated by a fractional inhibitory concentration (FIC) index. FIC was calculated as the MIC of ampicillin/sulbactam EGCg in combination divided by the MIC of ampicillin/sulbactam or EGCg alone, and the FIC index was obtained by adding the FICs. If an FIC index was р0.5, the combination was defined as synergic. Synergy was also determined by timekill assay and defined as a reduction of у2 log 10 of the initial inoculum (10 6 cfu/mL) at 24 h by the combination of ampicillin/sulbactam and EGCg at sub-MICs. The timekill assays were performed in triplicate and the data presented are mean Ϯ S.D.
Results
All 28 isolates were resistant to the tested -lactams, except for F-98, which was susceptible to imipenem. Sixty-eight per cent (19/28) of the strains produced -lactamase. Compared with ampicillin, oxacillin, cefmetazole and imipenem, ampicillin/sulbactam showed the strongest anti-MRSA effect, especially against the -lactamase-producing strains of MRSA and MSSA 226. The MIC range of ampicillin against -lactamase-producing MRSA changed from 64-256 to 16-32 mg/L in the presence of sulbactam, but no change was observed against -lactamase-non-producing MRSA. Nevertheless, MICs of ampicillin/sulbactam were still above its resistant breakpoint (у16 mg/L). EGCg also showed anti-MRSA effect with an MIC at 100 mg/L. When ampicillin/sulbactam at sub-MICs was further combined with EGCg at sub-MICs, potent synergy and dose-dependent reversion of the resistance against ampicillin/sulbactam were observed (Table) . The MIC 50 of ampicillin/sulbactam decreased to 8 mg/L in the presence of 6.25 mg/L EGCg, and the MIC 90 of ampicillin/sulbactam decreased to 4 mg/L in the presence of 25 mg/L EGCg. The synergic effect between ampicillin/sulbactam and EGCg was very similar for the -lactamase-producing and -lactamase-non-producing MRSA isolates. Time-kill curves show the synergic bactericidal effects of ampicillin/sulbactam and EGCg against two typical strains of the -lactamase-producing and -lactamase-nonproducing isolates (Figure) . The combinations resulted in a reduction of у2 log 10 of the initial inoculum at 24 h.
Discussion
Although MRSA is resistant to almost all -lactams, ampicillin in combination with -lactamase inhibitors may be effective, because most MRSA produce -lactamase, and ampicillin has a relative affinity for PBP2Ј 10-15 times greater than that of penicillinase-resistant -lactams. 7 Recently, an ampicillin and sulbactam combination (UNASYN) has been approved by US Food and Drug Administration for intravenous administration in the treatment of various infections.
About 10-15% of the dry weight of green tea is made up of catechins, including catechin, epicatechin, epigallocatechin, epicatechin gallate and EGCg. EGCg, the main constituent (60%) of tea catechins, has the best antibacterial activity. Interestingly, catechins demonstrate synergy with -lactams for MRSA. [3] [4] [5] We recently confirmed that EGCg is synergic with -lactams owing to interference with the integrity and biosynthesis of the bacterial cell wall through direct binding to peptidoglycan. The potent synergy between ampicillin/sulbactam and EGCg suggests a possible clinical use for MRSA infection. Tea, one of the most popular beverages, is consumed every day by billions of people. Capsules of tea catechins and EGCg are also becoming available for research and preclinical trial. Usually, EGCg concentration in tea beverage is 2-3 g/L. EGCg is absorbed through digestive tract and distributed to many organs of animals and humans. [8] [9] [10] In rat blood plasma, EGCg at 5.6 mg/L was detected after oral administration of EGCg at 500 mg/kg body weight, 8 and total catechins at 15-112 mg/L were detected at 2 h after oral dosing with catechins at 5 g/kg body weight. 9 In human blood plasma, EGCg at 2 mg/L was detected 3 h after taking 525 mg EGCg capsules. 10 Therefore, further experiments are needed to confirm the possibility of using ampicillin/sulbactam and EGCg combination against MRSA infections. 
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